Aclarion (ACON) Amortization of Deferred Charges (2023 - 2024)

Aclarion (ACON) posted Amortization of Deferred Charges of -$31129.0 for Q4 2024, down 380.16% on a QoQ basis from $11111.0 in Q3 2024, and down 109.12% year-over-year from $341497.0 in Q1 2024.

Aclarion (ACON) Amortization of Deferred Charges (2023 - 2024) Analysis & Trends

Aclarion's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at -$31129.0 for Q4 2024.

  • Quarterly Amortization of Deferred Charges fell 109.12% year-over-year to -$31129.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$31129.0 (down 103.69% YoY) and the FY2024 annual result came in at $471387.0, down 5.28% from the prior year.
  • Amortization of Deferred Charges was -$31129.0 for Q4 2024 at Aclarion, down from $11111.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $341497.0 in Q4 2023 and bottomed at -$31129.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 32.28 Bn 24.97 Bn 662.02 Mn
2 BrightSpring Health Services 14.62 Bn 13.72 Bn 482.22 Mn
3 Healthequity 8.35 Bn 8.08 Bn 256.31 Mn
4 Hinge Health 5.98 Bn 5.67 Bn 154.23 Mn
5 10x Genomics 5.88 Bn 5.34 Bn 106.18 Mn
6 MiniMed 4.50 Bn 4.20 Bn 480.00 Mn
7 Waystar Holding 4.47 Bn 4.41 Bn 216.84 Mn
8 Doximity 3.96 Bn 3.21 Bn 125.97 Mn
9 Privia Health 3.13 Bn 2.71 Bn -
10 Aclarion 4.69 Mn 4.69 Mn 3,750.00

Historic Data

Download Data
DateValue
Dec 31, 2024 -31,129.00
Dec 31, 2024 -31,129.00
Sep 30, 2024 11,111.00
Sep 30, 2024 11,111.00
Jun 30, 2024 156,053.00
Jun 30, 2024 156,053.00
Mar 31, 2024 335,352.00
Mar 31, 2024 335,352.00
Dec 31, 2023 341,497.00
Dec 31, 2023 341,497.00
Sep 30, 2023 127,639.00
Sep 30, 2023 127,639.00
Jun 30, 2023 28,520.00
Jun 30, 2023 28,520.00